Clinical Trials Directory

Trials / Unknown

UnknownNCT03600727

Propofol and Dexmedetomidine on Inflammation

Intraoperative Propofol and Dexmedetomidine on Peripheral Inflammation Induced by Hip or Knee Arthroplasty.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
The First Affiliated Hospital of Anhui Medical University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Dexmedetomidine, was reported to prevent postoperative delirium in elderly patients following its use in intensive care units. Possible mechanisms included improved quality of sleep and an inhibitory effect on inflammation. A greater number of studies indicated that propofol has negative effect on postoperative cognitive function. In this study, we planned to investigate the influence of these two different sedative drugs on peripheral inflammation induced by surgery and postoperative cognitive function of patients who will receive hip and knee arthroplasty.

Detailed description

Dexmedetomidine, was reported to prevent postoperative delirium in elderly patients following its use in intensive care units. Possible mechanisms included improved quality of sleep and an inhibitory effect on inflammation. A greater number of studies indicated that propofol has negative effect on postoperative cognitive function. In this study, patients who will receive hip and knee arthroplasty will be divided to two groups: Propofol group and Dexmedetomidine group. Spinal anesthesia will be used to meet the requirement of intraoperative analgesia. Patients in two groups will be sedated by propofol and dexmedetomidine, respectively. TNF-α and IL-6 in blood will be detected. And postoperative cognitive function of patients will be investigated. The objective of this study is to clarify the influence of these two different sedative drugs on peripheral inflammation induced by surgery, and the relationship with the change of postoperative cognitive function.

Conditions

Interventions

TypeNameDescription
DRUGPropofolPropofol will be used to offer intraoperative sedation for patients in Propofol group.
DRUGDexmedetomidineDexmedetomidine will be used to offer intraoperative sedation for patients in Dexmedetomidine group.

Timeline

Start date
2018-08-01
Primary completion
2018-09-01
Completion
2018-12-01
First posted
2018-07-26
Last updated
2018-07-26

Source: ClinicalTrials.gov record NCT03600727. Inclusion in this directory is not an endorsement.

Propofol and Dexmedetomidine on Inflammation (NCT03600727) · Clinical Trials Directory